Gene therapy education should be accessible to everyone.
We exist to make that happen.
Zaris Consulting is woman-owned and run organization focused on providing accessible gene therapy educational programming. Gene therapy is a class of new therapeutics, the first of which was approved by the FDA in 2017. The number of approved in human gene therapies is on track to double from five to ten this year, with dozens more in clinical development. Zaris Consulting is established as a neutral third-party educator with a focus on ethics, accessibility, and the patient perspective. Starting with educational sessions at public libraries, Zaris Consulting will expand their science educational offerings to patient groups, medical professionals, and pharmaceutical clients.
Zollie Yavarow, PhD, MA
Zaris Consulting is founded and run by Dr. Zollie Yavarow, a Massachusetts native and young woman entrepreneur. Dr. Yavarow earned her PhD in Pharmacology from Duke University studying mechanisms of disease. Recognizing a gap between her research and its application, she added a concurrent Master of Arts in Bioethics and Science Policy focusing on gene therapy and patient advocacy. Dr. Yavarow is a skilled science communicator and is uniquely poised to act as a translator among stakeholders in the gene therapy space. She is passionate about science education as a means of medical access and informed medical decision making and is excited to provide educational content to support this.
Community Partners
